X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14174) 14174
Book Review (1741) 1741
Publication (1053) 1053
Magazine Article (59) 59
Conference Proceeding (51) 51
Book Chapter (22) 22
Book / eBook (6) 6
Newspaper Article (2) 2
Data Set (1) 1
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12986) 12986
humans (9594) 9594
piperidines - therapeutic use (8009) 8009
male (7231) 7231
animals (5676) 5676
female (5238) 5238
piperidines - pharmacology (5110) 5110
pharmacology & pharmacy (3437) 3437
middle aged (3095) 3095
adult (2876) 2876
rats (2705) 2705
aged (2602) 2602
piperidines - administration & dosage (2073) 2073
piperidines - adverse effects (1982) 1982
mice (1917) 1917
dose-response relationship, drug (1782) 1782
neurosciences (1692) 1692
indans - therapeutic use (1421) 1421
double-blind method (1346) 1346
treatment outcome (1325) 1325
psychiatry (1157) 1157
abridged index medicus (1116) 1116
alzheimer disease - drug therapy (1026) 1026
cholinesterase inhibitors - therapeutic use (1016) 1016
time factors (1002) 1002
rats, sprague-dawley (1001) 1001
clinical trials as topic (942) 942
pyrazoles - pharmacology (914) 914
clinical neurology (889) 889
donepezil (849) 849
analysis (824) 824
piperidines - chemistry (821) 821
double-blind (802) 802
disease models, animal (798) 798
piperidines - pharmacokinetics (768) 768
adolescent (761) 761
aged, 80 and over (709) 709
alzheimer's disease (704) 704
rats, wistar (695) 695
drug therapy (689) 689
oncology (673) 673
chemistry, medicinal (604) 604
drug therapy, combination (578) 578
article (576) 576
biochemistry & molecular biology (576) 576
research (572) 572
receptor, cannabinoid, cb1 - antagonists & inhibitors (566) 566
efficacy (565) 565
pyrazoles - therapeutic use (554) 554
piperidines (553) 553
administration, oral (549) 549
nootropic agents - therapeutic use (541) 541
brain (537) 537
alzheimers-disease (522) 522
care and treatment (521) 521
anesthesiology (514) 514
dementia (512) 512
pharmacology (492) 492
cisapride (481) 481
in vitro techniques (480) 480
drug interactions (476) 476
medicine, general & internal (471) 471
remifentanil (471) 471
cancer (463) 463
mice, inbred c57bl (455) 455
pharmacokinetics (450) 450
pharmacology/toxicology (448) 448
schizophrenia - drug therapy (442) 442
piperidines - metabolism (441) 441
rodents (432) 432
expression (430) 430
rat (427) 427
medicine & public health (421) 421
structure-activity relationship (416) 416
prospective studies (409) 409
child (404) 404
diabetes mellitus, type 2 - drug therapy (401) 401
drugs (395) 395
inhibition (393) 393
cell line, tumor (392) 392
blood pressure - drug effects (391) 391
health aspects (390) 390
antineoplastic agents - therapeutic use (389) 389
pyrimidines - therapeutic use (385) 385
randomized controlled trials as topic (385) 385
in-vitro (384) 384
indans - pharmacology (381) 381
clinical trials (379) 379
activation (377) 377
rivastigmine (376) 376
hypoglycemic agents - therapeutic use (371) 371
protein kinase inhibitors - therapeutic use (371) 371
apoptosis (369) 369
receptors (368) 368
behavior, animal - drug effects (366) 366
analysis of variance (362) 362
endocrinology & metabolism (361) 361
receptor (359) 359
young adult (350) 350
pyridines - pharmacology (349) 349
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12821) 12821
German (369) 369
French (292) 292
Japanese (155) 155
Italian (126) 126
Spanish (112) 112
Russian (98) 98
Chinese (66) 66
Polish (56) 56
Portuguese (37) 37
Czech (29) 29
Danish (23) 23
Dutch (12) 12
Norwegian (12) 12
Hungarian (11) 11
Romanian (8) 8
Swedish (6) 6
Slovak (5) 5
Finnish (3) 3
Hebrew (3) 3
Bulgarian (2) 2
Serbian (2) 2
Turkish (2) 2
Afrikaans (1) 1
Croatian (1) 1
Korean (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 829 - 838
Alectinib, a potent ALK tyrosine kinase inhibitor, was more effective and somewhat less toxic than crizotinib when used as primary therapy in patients with ALK... 
RESISTANT | MEDICINE, GENERAL & INTERNAL | MODELS | ANTITUMOR-ACTIVITY | INHIBITOR ALECTINIB | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Central Nervous System Neoplasms - secondary | Young Adult | Pyridines - adverse effects | Anaplastic Lymphoma Kinase | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Pyrazoles - adverse effects | Pyridines - therapeutic use | Crizotinib | Carbazoles - adverse effects | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Animals | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Intention to Treat Analysis | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Central Nervous System Neoplasms - drug therapy | Drugs | Care and treatment | Analysis | Comparative analysis | Lung cancer, Non-small cell | Health aspects | Systemic diseases | Toxicity | Lung cancer | Central nervous system | Oncology | Nervous system | Metastasis | Radiation therapy | Patients | Lymphoma | Cancer therapies | Survival | Mutation | Protein-tyrosine kinase | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2016, Volume 34, Issue 2, pp. 123 - 129
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 9993, pp. 552 - 561
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 10/2017, Volume 69, Issue 10, pp. 1960 - 1968
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2016, Volume 34, Issue 7, pp. 661 - 668
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10089, pp. 29 - 39
Summary Background Alectinib, a potent, highly selective, CNS-active inhibitor of anaplastic lymphoma kinase (ALK), showed promising efficacy and tolerability... 
Internal Medicine | ANAPLASTIC LYMPHOMA KINASE | MEDICINE, GENERAL & INTERNAL | SAFETY | CH5424802 | AF-001JP | ADVANCED NSCLC | INHIBITORS | CHEMOTHERAPY | Single-Blind Method | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Piperidines - blood | Brain Neoplasms - secondary | Pyridines - adverse effects | Carcinoma, Non-Small-Cell Lung - secondary | Neoplasm Grading | Antineoplastic Agents - adverse effects | Pyrazoles - blood | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Carbazoles - blood | Pyrazoles - adverse effects | Pyridines - therapeutic use | Carcinoma, Non-Small-Cell Lung - pathology | Carbazoles - adverse effects | Lung Neoplasms - enzymology | Kaplan-Meier Estimate | Receptor Protein-Tyrosine Kinases - metabolism | Protein Kinase Inhibitors - blood | Pyridines - blood | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Antineoplastic Agents - blood | Aged | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Medical colleges | Respiratory agents | Care and treatment | Lymphomas | Lung cancer, Non-small cell | Product development | Pharmaceutical industry | Analysis | Toxicity | Funding | Lung | Lung cancer | Central nervous system | Medical services | Metastasis | Kinases | Recruitment | Motivation | Audio frequencies | Safety | Toxic diseases | Drug dosages | Protein-tyrosine kinase | Effectiveness | Cut-off | Data processing | Group dynamics | Patients | Survival | Lymphoma | Chemotherapy | Inhibitors | Interactive systems | Death | Mutation | Cancer | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
11.